Post by Harvard University
2,960,071 followers
A new paper co-authored by Harvard Medical School's Merit Cudkowicz found that a new drug can radically slow and even reverse the course of ALS in a small subset of patients with a rare genetic variant.
2,960,071 followers
A new paper co-authored by Harvard Medical School's Merit Cudkowicz found that a new drug can radically slow and even reverse the course of ALS in a small subset of patients with a rare genetic variant.